- Abstract Number: 473
RA Presents in Disease Patterns Impacting Treatment Response
- Abstract Number: 64
Rab4A Controls mTOR Pathway Activation, Pro-inflammatory Lineage Development, and Disease Pathogenesis in Lupus-prone Mice
- Abstract Number: 82
Rab4A Increases Mitochondrial Oxidative Stress and Glutathione Disulfide Accumulation That Underlie Neurobehavioral Changes in Lupus-Prone Mice
- Abstract Number: PP05
Race for Relapsing Polychondritis Drives Awareness, Accelerates Research, and Improves the Quality of My Life: How Motorsports Help Me Overcome the Hopelessness of an Incurable, Rare Disease
- Abstract Number: 1853
Racial Differences in Highly Effective Contraceptive Use Among Medicaid Beneficiaries with SLE
- Abstract Number: 1143
Racial Disparities in Factors Associated with SLICC Damage Score Among Patients with SLE
- Abstract Number: 1141
Racial Disparities in Lupus Medication Adherence
- Abstract Number: 1848
Racial Disparities in Septic and Aseptic Total Knee Replacement Revision Risk: A Study Using Four State-wide Inpatient Databases
- Abstract Number: 584
Radiographic Association of Hip and SI Joints in Ankylosing Spondylitis Patients
- Abstract Number: 2849
Radiographic Progression During a 10-Year Follow-Up : Results from the French Cohort ESPOIR
- Abstract Number: 2219
Randomized Control Study in Glucocorticoid-Induced Osteoporosis Treated with Bisphosphonate or Denosumab (GOBID)
- Abstract Number: 2878
Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Phase 2b Study to Demonstrate the Safety and Efficacy of Tildrakizumab, a High-Affinity Anti–Interleukin-23P19 Monoclonal Antibody, in Patients with Active Psoriatic Arthritis
- Abstract Number: 350
Rapid Reduction in Uric Acid Is Associated with Recurrent Cardiovascular Events
- Abstract Number: 952
Rate of Thirty-Day Readmissions in Systemic Lupus Erythematosus Rivals Congestive Heart Failure and Exceeds the General Medicare Population
- Abstract Number: 1301
Rates of Incident Radiographic Knee Osteoarthritis and Knee Replacement by Sex and Race, Across Three Large, Diverse Cohorts
- Abstract Number: 2451
Rates of Myocardial Infarction, Stroke, and Revascularization Among Patients with Psoriatic Arthritis Treated with Apremilast, Biologics, DMARDs, and Corticosteroids in the US MarketScan Database
- Abstract Number: 2441
Rates of Treated Depression Among Patients with Psoriatic Arthritis Treated with Apremilast, Biologics, DMARDs, and Corticosteroids in the US MarketScan Database
- Abstract Number: 2660
Rationalizing the Use of MRI of the Scalp Arteries in the Diagnosis of Giant Cell Arteritis Through Multivariable Predictive Modelling
- Abstract Number: 1313
Readmissions After Staged vs Simultaneous Bilateral Total Knee Replacements (TKR)
- Abstract Number: 1495
Real Life 12 Year Retention Rate of Subcutaneous Anti-TNF in Spondyloarthritis. Results from a Multicenter Cohort of 1170 Patients
- Abstract Number: 2686
Real Life Data over 4 Years from a Fast Track GCA Pathway in Coventry
- Abstract Number: 1400
Real Life Retention of Tofacitinib in Patients with Rheumatoid Arthritis
- Abstract Number: 2112
Real Life Serious Infections in Patients with Chronic Inflammatory Arthritis on Treatment with TNF Inhibitors
- Abstract Number: 1530
Real World Effectiveness of Secukinumab in Patients with Ankylosing Spondylitis: Findings from a Recent Cross Sectional Survey of Rheumatologists and Patients in Europe
- Abstract Number: 1443
Real World Switching Patterns of Etanercept Original and Biosilmilar in Germany
- Abstract Number: 1431
Real-Life Golimumab Persistence in Patients with Chronic Inflammatory Rheumatic Disease: Results of the GO PRACTICE Study
- Abstract Number: 2684
Real-world Comparative Study of Methotrexate vs Tocilizumab in Patients with Giant Cell Arteritis with Large Vessel Involvement
- Abstract Number: 2352
Real-World Distribution of Anti-Cyclic Citrullinated Peptide Concentrations and Impact on Treatment Patterns of Patients with Rheumatoid Arthritis
- Abstract Number: 244
Real-World Evidence Associated with the Treatment of Systemic Lupus Erythematosus in the USA, UK, France, and Germany: A Structured Review
- Abstract Number: 419
Real-World Evidence on the Early Effects of Golimumab on Work Productivity and Activity Impairment in Patients with Spondyloarthritis: Interim Results from a Prospective, Observational Study
- Abstract Number: 204
Real-World Evidence: Clinical and Economic Burden of Anemia, Venous Thromboembolism, and Malignancy Among Rheumatoid Arthritis Patients Switching from First Biologic DMARD to Another Treatment in the US
- Abstract Number: 1374
Real-World Evidence: Infections Among RA Patients Switching from First Biologic DMARD to Another Treatment in the US
- Abstract Number: 1205
Real-World Remission Outcomes in the First Year Following RA Diagnosis Vary Considerably with the Disease Activity Index Used and a Sizable Proportion Have Persistent Active Disease Across All Measures: Results from the Canadian Early Arthritis Cohort (CATCH)
- Abstract Number: 2444
Real-world Treatment Patterns Among Patients with Psoriatic Arthritis Treated with Biologic Therapies
- Abstract Number: 1481
Real-World Use of Apremilast in Combination with Biologic Therapy in Patients with Psoriatic Arthritis: Findings from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
- Abstract Number: 2698
Reasons for Initiation of Canakinumab of Patients with Systemic Juvenile Idiopathic Arthritis: A Retrospective Medical Chart Review from the United States
- Abstract Number: 203
Recent Use, Missed Doses and Discontinuation of Infliximab in a Population-Based Cohort: Comparisons of Biosimilar and Originator Exposures
- Abstract Number: PP04
Reclaiming Medical Autonomy Through Healthcare Advocacy
- Abstract Number: 631
Recognition of Inflammatory Back Pain by US Healthcare Providers and Barriers to Specialist Referral
- Abstract Number: 1257
Recommendation on Colchicine Dosing and Definition of Colchicine Resistance/Intolerance in the Management of Familial Mediterranean Fever
- Abstract Number: 2485
Red Cell Distribution Width Positively Correlates with Atherosclerotic Cardiovascular Disease Risk Score in Psoriatic Arthritis and Decreases with BDMARD Therapy
- Abstract Number: 736
Reduced Circulating Levels of Inorganic Pyrophosphate Are Associated with Ectopic Calcification in Scleroderma Spectrum Disorders
- Abstract Number: 1916
Reduced DNASE1L3 Activity in Sporadic SLE Is Linked to Increased DNA Load of Microparticles, Reactivity to DNASE1L3-sensitive Antigens, and Lupus Nephritis
- Abstract Number: 1664
Reducing the Number of Rituximab Infusions at Onset of Maintenance Therapy for ANCA-associated Vasculitides: Results of a Post Hoc Analysis from a Randomized–controlled Trial
- Abstract Number: 1422
Reduction in CD4 TEMRA Cells and Its Association with DAS28 (CRP) < 2.6 Treatment Response with Abatacept in Patients with Early, ACPA+, DMARD-Naïve RA
- Abstract Number: 935
Reduction of Anterior Uveitis Flares in Patients with Axial Spondyloarthritis Following 1 Year of Treatment with Certolizumab Pegol: 48-Week Interim Results from a 96-Week Open-Label Study
- Abstract Number: 2189
Reference Curves for the Knee Injury and Osteoarthritis Outcome Score in the Middle-aged Dutch Population
- Abstract Number: 2471
Regional Difference in Disease Burden Among Patients with Psoriatic Arthritis: A Multi-Center Study
- Abstract Number: 1976
Regulation of Interleukin-1β (IL-1β)-induced COX-2 Expression and IL-6 and MMP-1 Production in Human OA Synovial Fibroblasts by Guanylate Binding Protein 5
- Abstract Number: 31
Regulation of Neutrophil Extracellular Traps by Apremilast (phosphodiesterase 4 Inhibition)
- Abstract Number: 1014
Regulatory Role of IL-23 and Its Receptor System in Spondyloarthritis and Its Therapeutic Relevance in anti-IL-17 Failure Patients
- Abstract Number: 948
Relapsing Cryoglobulinemic Vasculitis Following Successful HCV Eradication by Interferon-Free Direct Acting Antivirals, an International Multicenter Study
- Abstract Number: 2183
Relation of Intra-Articular Knee Mineralization on CT to Knee Pain in People with or at Risk of Knee Osteoarthritis
- Abstract Number: 2182
Relation of MRI-detected Structural Damage in the Knee to Anterior Knee Pain: The MOST Study
- Abstract Number: 1315
Relation of MRI-detected Structural Damage in the Patellofemoral Joint to Pain and Performance Based Function: The MOST Study
- Abstract Number: 619
Relation of Therapies for Ankylosing Spondylitis to Risk of Total Hip and Knee Arthroplasty
- Abstract Number: 213
Relationship Between a History of Abuse and Fibromyalgia Symptoms and Severity: Data from the Cleveland Clinic Fibromyalgia Registry
- Abstract Number: 1440
Relationship Between Adalimumab Concentrations, Plasma Cytokines, Anti-drug Antibodies and Disease Activity in Rheumatoid Arthritis
- Abstract Number: 710
Relationship Between High-Resolution Computer Tomography and FVC% Predicted for Classification of Pulmonary Hypertension in Systemic Sclerosis
- Abstract Number: 2610
Relationship Between Parenchymal and Vascular Features in Systemic Sclerosis-Interstitial Lung Disease: Results from Quantitative Analysis of Chest Computed Tomography
- Abstract Number: 138
Relationship Between Recurrent Thrombosis and the Antiphospholipid Antibodies Profile in a Cohort of Patients with Antiphospholipid Syndrome
- Abstract Number: 2470
Relationship Between Serum Calprotectin Level and Presence of Subclinical Atherosclerosis and Arterial Stiffness in Patient with Psoriatic Arthritis
- Abstract Number: 2210
Relationship Between Structural Spine Involvement and the Scanographic Bone Attenuation Coefficient of L1 in a Population of 73 Patients with Ankylosing Spondylitis
- Abstract Number: 1362
Relationship Between Waking Functions and Disease Activity in Rheumatoid Arthritis Patients Analyzed by Wearable Device
- Abstract Number: 1633
Relationship Between YKL-40, VEGF, and IL-5 in Borderline mPAP and Pulmonary Hypertension in Systemic Sclerosis
- Abstract Number: 1105
Relationships Among Cognitive Emotion Regulation, Body Image, Family and Marital Function and Quality of Life in Chinese Female Patients with Systemic Lupus Erythematosus
- Abstract Number: 1222
Relationships Between Allopurinol Dose, Oxypurinol Levels and Serum Urate – in Search of an Oxypurinol Therapeutic Concentration
- Abstract Number: 2382
Relationships Between DAS28 Response and Clinical, Functional and Radiographic Outcomes in Year 2 of the COMET Study of Etanercept in Patients with Rheumatoid Arthritis
- Abstract Number: 2514
Relationships Between Minimal Disease Activity and Patient-Reported Outcomes in Patients with Psoriatic Arthritis: Post Hoc Analysis of Two Phase 3 Studies
- Abstract Number: 2513
Relationships Between Psoriatic Arthritis Disease Activity Score and Patient-Reported Outcomes in Patients with Psoriatic Arthritis: Post Hoc Analysis of Two Phase 3 Studies
- Abstract Number: 2465
Reliability and Validity of the Self‐Administered Comorbidity Questionnaire in Psoriatic Arthritis
- Abstract Number: 1832
Reliability of Traditional Cardiovascular Risk Calculators in Predicting Risk of Cardiovascular Disease in Systemic Sclerosis
- Abstract Number: 2840
Reliability, Validity and Responsiveness of PROMIS PF-20 in Patients with Inflammatory Myopathy
- Abstract Number: 1684
Remission and Low Disease Activity State in Patients with Granulomatosis with Polyangiitis and Microscopic Polyangiitis: Prevalence and Impact on Damage Accrual
- Abstract Number: 2908
Remission in Patients with Rheumatoid Arthritis Receiving Triple Therapy Compared to Biological Therapy – A Swedish Nationwide Register Study
- Abstract Number: 1564
Renal Arteriosclerosis Predicts Cardiovascular Disease in Lupus Nephritis
- Abstract Number: 2786
Renal Histopathological Classifications Predict the Renal Outcomes of Plasma Exchange-Treated ANCA-Associated Vasculitides with Renal Failure
- Abstract Number: 1018
Renal Single Cell Genomics Links Type II Interferon and Lupus Nephritis in African-Americans
- Abstract Number: 335
Renal Transplant Complications in Patients with and Without Gout
- Abstract Number: 236
Repeat Muscle Pressures Measured in Fibromyalgia Patients and Compared with Pain Scores
- Abstract Number: 592
Replacement of Radiographic Sacroilitis by MRI Structural Lesions: What Is the Impact on Classification of Axial Spondyloarthritis in the ASAS Classification Cohort?
- Abstract Number: 2354
Replication of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis
- Abstract Number: 2169
Reporting of Adverse Events in Randomized Controlled Trials of Therapeutic Exercise for Knee Osteoarthritis: A Systematic Review
- Abstract Number: 2282
Reproductive Counseling Documentation Practices for Women Receiving Teratogenic Medications in an Academic Rheumatology Clinic Serving a Medicaid/Medicare Patient Population
- Abstract Number: 2239
Reproductive Health Awareness and Needs: Assessment of Parents, Female Adolescents, and Young Adults with Pediatric Rheumatic Diseases
- Abstract Number: 2280
Reproductive Health Intention Screening in Women with Systemic Rheumatic Diseases: Low Uptake and Gender-Specific Provider Patterns Following a Standardized Intervention
- Abstract Number: 1528
Resolution of Enthesitis and Dactylitis Is Maintained over Two Years of Ixekizumab Treatment in Patients with Psoriatic Arthritis
- Abstract Number: 1841
Resolution of Vascular Inflammation in Patients with Giant Cell Arteritis Receiving Glucocorticoids, Methotrexate or Tocilizumab Treatment: Data from the Italian/German RIGA Study
- Abstract Number: 2735
Response Gene to Complement -32 Exerts Proinflammatory and Profibrotic Effects in Immune Complex Gediated Glomerulonephritis
- Abstract Number: 1279
Response Rate and Sustained Remission in Idiopathic Inflammatory Myopathies Receiving Conventional Immunosuppressive Stepwise Management
- Abstract Number: 940
Response to Placebo in Randomized Clinical Trials with Biologics in Non-renal, Non-neuropsychiatric Systemic Lupus Erythematosus: A Systematic Review and Pooled Analysis
- Abstract Number: 2678
Response to Tocilizumab in Patients with Giant Cell Arteritis, According to Ischemic vs Systemic Symptoms
- Abstract Number: 2617
Responsiveness to Change of the Modified Rodnan Skin Score in a Phase I/II Double-Blind Randomized Placebo-Controlled Trial
- Abstract Number: 1179
Resting-State Functional Connectivity of Pain Processing Brain Region Associated with Therapeutic Response to Biologics in Rheumatoid Arthritis and Spondyloarthritis
- Abstract Number: 578
Restricted Work Participation Relates to High Disease Activity in Spondyloarthritis Patients
- Abstract Number: 2089
Restricting Activity to Evade Knee Symptoms Is Associated with Worse Physical Function and Radiographic Osteoarthritis
- Abstract Number: 1429
Results at 6 Months of Abatacept vs TNF-α Blockers in Patients with Severe, Long-standing, DMARDs Resistant Rheumatoid Arthritis
- Abstract Number: 824
Results from a Randomized Controlled Trial of the Safety of the Live Varicella Vaccine in TNF-Treated Patients
- Abstract Number: 2232
Results of the Implementation of a Bone Health Program in Patients with Rheumatoid Arthritis to Improve the Evaluation of Osteoporosis
- Abstract Number: 2544
Results of the Open-label, Non-randomized 52-Week Study to Evaluate Treatment Holidays and Rebound Phenomenon After Treatment with Belimumab in Patients with SLE
- Abstract Number: 1512
Retention Rates and Response of Anti-TNF Treatments in the Enteropathic Spondylitis: HUR-BIO Real Life Results
- Abstract Number: 611
Retina of Ankylosing Spondylitis Patients Shows Early Signs of Atherosclerotic Disease in Comparison with Healthy Controls
- Abstract Number: 383
Retroperitoneal Fibrosis- a Single Center Experience
- Abstract Number: 1783
Reversible Dysregulation of Renal Circadian Rhythm in Lupus Nephritis
- Abstract Number: 1757
Review of Effectiveness of an Intensive Rehabilitation Programme in Managing Strength, Pain and Function in 123 Young People with Rheumatological Conditions
- Abstract Number: 699
Revising the SLEDAI-2K to Include Additional Constitutional Symptoms to More Accurately Assess Lupus Disease Activity
- Abstract Number: 582
Rheumacheck – Spondyloarthritis: Comprehensive Fast-track Diagnosis Program. What Benefits Does It Offer in a Developing Country?
- Abstract Number: 2125
Rheumatic Fever in a Tertiary Medical Center – 25 Years of Follow Up
- Abstract Number: 2158
Rheumatic Immune Related Adverse Events Associated with Cancer Immunotherapy: A Nationwide Multi-centre Canadian Cohort from the Canadian Research Group of Rheumatology in Immuno-oncology (CanRIO)
- Abstract Number: 2138
Rheumatic Immune-related Adverse Effects from Checkpoint Inhibitor Immunotherapy in Patients with Solid Tumors in a Latin American Population
- Abstract Number: 2139
Rheumatic Immune-Related Adverse Events Associated with Treatment with Immune Checkpoint Inhibitors: A Multicenter Study of 38 Cases
- Abstract Number: 1810
Rheumatic Toxicities Associated with Immune Checkpoint Inhibitors: An Observational, Retrospective, Pharmacovigilance Study
- Abstract Number: 1184
Rheumatoid Arthritis Activity Assessment with Cellphone Thermal Camera Imaging Compared to Clinical and Ultrasound Assessments
- Abstract Number: 260
Rheumatoid Arthritis Associated with Longer Hospital Stays in Patients Admitted with Venous Thromboembolism: A Nationwide Analysis 2010-2014
- Abstract Number: 2228
Rheumatoid Arthritis Disease Activity Is Associated with Low Femoral Neck Bone Mineral Density in a Diverse Cohort of Patients
- Abstract Number: 1898
Rheumatoid Arthritis in Pregnancy and Offspring School Performance. a Danish Nationwide Register-Based Study
- Abstract Number: 877
Rheumatoid Arthritis Patients’ Perspectives on Tapering of Biologics: A Qualitative Study
- Abstract Number: 550
Rheumatoid Arthritis Treatment with Filgotinib: Week 156 Safety and Efficacy Data from a Phase 2b Open-Label Extension Study
- Abstract Number: 342
Rheumatologist Care Is Associated with Fewer Emergency Room Visits by Persons with Gout
- Abstract Number: 1112
Rheumatologists’ Opinions and Use of Telemedicine in the Southwestern U.S
- Abstract Number: 1797
Rheumatology Mechanism Madness: A Pilot Collaborative Learning Activity for Rheumatology Trainees
- Abstract Number: 2905
Rilonacept in Recurrent Pericarditis: Efficacy and Safety Data from an Ongoing Phase 2 Pilot Clinical Trial
- Abstract Number: 734
Risk Assessment in Connective Tissue Disease Associated Pulmonary Arterial Hypertension
- Abstract Number: 202
Risk Factors Associated with Serious Infections Among Users of Biosimilar and Originator Infliximab Therapies
- Abstract Number: 1607
Risk Factors for Avascular Necrosis in SLE: A Multivariate Model
- Abstract Number: 351
Risk Factors for Cutaneous Reactions to Allopurinol in Kinh Vietnameses: Results of a Prospective Study in Ho Chi Minh City
- Abstract Number: 2114
Risk Factors for Cytomegalovirus Infection in Patients with Autoimmune Diseases
- Abstract Number: 1306
Risk Factors for Pain After Total Joint Replacement in Osteoarthritis: Different Pain Measures, Distinct Predictors?
- Abstract Number: 2170
Risk Factors for Poor Outcomes After Hip Fracture Patients in the Robust Elderly: Are Patient Reported Outcomes Important?
- Abstract Number: 2108
Risk Factors for Pulmonary Nontuberculous Mycobacterial Disease in Rheumatoid Arthritis Patients
- Abstract Number: 2300
Risk Factors for Transfusion and Use of Tranexemic Acid in Patients with Rheumatoid Arthritis Undergoing Total Hip Arthroplasty and Total Knee Arthroplasty
- Abstract Number: 1840
Risk Factors for Treatment Failure in Patients with Giant Cell Arteritis Treated with Tocilizumab Plus Prednisone versus Prednisone Alone
- Abstract Number: 1283
Risk Factors of Cancer-Associated Inflammatory Myopathies: A Multicenter Study
- Abstract Number: 2872
Risk of 30-day Readmission and Adverse Events After Primary Hip or Knee Arthroplasty: A Comparison of Patients with Rheumatoid Arthritis versus Osteoarthritis Using the Nationwide Readmission Database
- Abstract Number: 2781
Risk of Cardiovascular Disease Associated with the Use of Glucocorticoids in Patients with Incident Systemic Lupus Erytematosus: A Population-based Study
- Abstract Number: 805
Risk of Cardiovascular Disease in SLE Is Significant Early and Highlights Racial Disparities
- Abstract Number: 2365
Risk of Diabetes Treatment Switching or Intensification Associated with Use of Abatacept versus Other Biologic Drugs in Patients with Rheumatoid Arthritis and Diabetes Mellitus
- Abstract Number: 2368
Risk of Diverticulitis and Gastro-Intestinal Perforation in Rheumatoid Arthritis Treated with Tocilizumab Compared to Rituximab and Abatacept: A Prospective Propensity-matched Cohort Study
- Abstract Number: 732
Risk of Heart Valve Disease in Systemic Sclerosis
- Abstract Number: 1395
Risk of Immunization to Rituximab in Systemic Autoimmune Diseases and Rheumatoid Arthritis: Frequency and Risk Factors. Analysis of the Efficacy of an Alternative Treatment by Ofatumumab
- Abstract Number: 1339
Risk of Immunotherapy Related Toxicity in Patients with Rheumatoid Arthritis
- Abstract Number: 2333
Risk of Incident Myocardial Infarction Among Disabled Patients with Rheumatoid Arthritis Who Were Beneficiaries of the Social Security Disability Insurance
- Abstract Number: 2434
Risk of Lymphoma and Thyroid Cancer in Primary Sjögren’s Syndrome Measured Using the Korean Health Insurance Claims Database
- Abstract Number: 2371
Risk of Malignancies Across Biologic Classes in Rheumatoid Arthritis: Analysis of a National Claim Database
- Abstract Number: 849
Risk of Malignancies Associated with Biologics in Rheumatoid Arthritis: Analysis of a National Claim Database
- Abstract Number: 2053
Risk of Non-vertebral Fracture in Gout Compared to Rheumatoid Arthritis
- Abstract Number: 2675
Risk of Potential Glucocorticoid-Related Adverse Events in Patients with Giant Cell Arteritis: Results from a US-based Electronic Health Records Database
- Abstract Number: 1091
Risk of Preterm Birth by Timing of Lupus Diagnosis Among Women in the Georgia Lupus Registry
- Abstract Number: 848
Risk of Serious Infection with Long-Term Use of Low-Dose Glucocorticoids in Patients with Rheumatoid Arthritis
- Abstract Number: 2273
Risk of Serious Infections in Offspring According to TNFi Subtypes
- Abstract Number: 2826
Risk of Serious Infections in Tofacitinib versus Other Biologic Drug Initiators in Patients with Rheumatoid Arthritis: A Multi-database Cohort Study
- Abstract Number: 196
Risk of Subsequent Atherosclerotic Cardiovascular Disease After the First Unprovoked Venous Thromboembolism in Patients with Rheumatoid Arthritis
- Abstract Number: 2393
Risk of Thromboembolism with Janus Kinase Inhibitors: A Systematic Review and Meta-Analysis of Randomized Placebo Controlled Trials
- Abstract Number: 1686
Risk of Vasculitis Associated with Inflammatory Bowel Diseases: Evidence for a Role of TNF-α Blockers
- Abstract Number: 1894
Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Initiating Biologic and Non-biologic DMARDs, a Population-based Study
- Abstract Number: 2697
Risk Score of Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis
- Abstract Number: 2904
Rituximab as Rescue Therapy in Treatment-Refractory CTD-ILD
- Abstract Number: 2619
Rituximab for Eosinophilic Granulomatosis with Polyangiitis: A Systematic Review of Observational Studies
- Abstract Number: 793
Rituximab for Rapidly Progressive Juvenile Systemic Sclerosis: A Proof-of-concept Study in Four Patients
- Abstract Number: 740
Rituximab Rescue Therapy in Patients with Systemic Sclerosis or Other Connective Tissue Diseases and Refractory Interstitial Lung Disease
- Abstract Number: 2131
Rituximab Safety and Persistence in Patients with Systemic Autoimmune Diseases
- Abstract Number: 2141
Rituximab Therapy for Interstitial Pneumonia with Autoimmune Features (IPAF): A Case Series of Nineteen Patients
- Abstract Number: 2521
Rituximab Treatment Is Not Associated with Increased Risk of Infection or Mortality in Refractory SLE Patients: Results from the British Isles Lupus Assessment Group Biologics Registry (BILAG-BR)
- Abstract Number: 1000
RKIP, as an Upstream Regulator of Intracellular Signaling, Exerts Anti-arthritic Effect in Fibroblast-like Synoviocyte and Collagen-induced Arthritis
- Abstract Number: 1036
RNA Sequencing of PBMCs Reveals Estrogen-Mediated Upregulation of Micro-RNA Processing Machinery
- Abstract Number: 2045
RNA Sequencing of Plasma and Urine-derived Extracellular Vesicles from Lupus Nephritis Patients Identifies Disease-associated Small RNA Signatures and Putative Therapeutic Targets
- Abstract Number: 1595
Role of Aerobic Exercise in Modulating Fatigue in Women with Systemic Lupus Erythematosus
- Abstract Number: 371
Role of Alternative Immunosuppressant Therapy in Management of Cardiac Sarcoidosis
- Abstract Number: 2238
Role of Clinical Impact, Disease-specific Knowledge and Beliefs About Medication on Therapeutic Adherence in Rheumatoid Arthritis: An Integrative Structural Equation Modeling Approach
- Abstract Number: 2154
Role of Insulin Resistance and Inflammation on Resting Energy Expenditure in Patients with Rheumatoid Arthritis
- Abstract Number: 1927
Role of Mitochondrial DNA from OA Patients in Cellular Apoptosis, Senescence and Autophagy
- Abstract Number: 39
Role of Sialic Acid in the Aggressive Phenotype of RA FLS
- Abstract Number: 2420
Role of T Follicular Helper Cells and T Peripheral Helper Cells in the Activation of B Cells in Sjögren Syndrome
- Abstract Number: 24
Role of Trained Immunity in the Pathogenesis of Erdheim-Chester Disease
- Abstract Number: 10
Roles of Histone Acetyltransferases CBP/p300 and Transcriptional Factor RORα/REV-ERBα Against TNFα-induced CCL2 Expression in RA-FLSs
- Abstract Number: 1877
Romosozumab Improves Lumbar Spine Bone Mineral Density and Bone Strength Greater Than Alendronate as Assessed by Quantitative Computed Tomography and Finite Element Analysis in the ARCH Trial
- Abstract Number: 2424
RORγt Antagonist Attenuates Experimental Sialadenitis Like Sjögren’s Syndrome via Inhibition of CD25 Expression on CD4+ T Cells
- Abstract Number: 1559
Routine Clinical Pathology Measurements Are Predictive of the Risk of Organ Damage Accrual in SLE
2019 ACR/ARP Annual Meeting
November 8-13, 2019. Atlanta, GA.